Comparison between Accretion Pharmaceuticals IPO and Indicosmic Infotech IPO.
Accretion Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Indicosmic Infotech IPO is a SME Bookbuilding proposed to list at NSE SME.
| Accretion Pharmaceuticals IPO | Indicosmic Infotech IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Jawa Capital Services Pvt.Ltd. | Comfort Securities Ltd. |
| Registrar | Kfin Technologies Ltd. | Kfin Technologies Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | Comfort Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Accretion Pharmaceuticals IPO is up to ₹28.26 Cr whereas the issue size of the Indicosmic Infotech IPO is up to ₹0.00 Cr. The final issue price of Accretion Pharmaceuticals IPO is ₹101.00 per share and of Indicosmic Infotech IPO is .
| Accretion Pharmaceuticals IPO | Indicosmic Infotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹96.00 per share | |
| Issue Price (Upper) | ₹101.00 per share | |
| Issue Price (Final) | ₹101.00 per share | |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | |
| Fresh Issue Size | 27,98,400 shares | 32,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹28.26 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 27,98,400 shares | 32,00,000 shares |
| Issue Size Total (Amount) | up to ₹28.26 Cr | up to ₹0.00 Cr |
Accretion Pharmaceuticals IPO opens on May 14, 2025, while Indicosmic Infotech IPO opens on . The closing date of Accretion Pharmaceuticals IPO and Indicosmic Infotech IPO is May 16, 2025, and , respectively.
| Accretion Pharmaceuticals IPO | Indicosmic Infotech IPO | |
|---|---|---|
| Anchor Bid Date | May 13, 2025 | |
| Issue Open | May 14, 2025 | |
| Issue Close | May 16, 2025 | |
| Basis Of Allotment (Tentative) | May 19, 2025 | |
| Initiation of Refunds (Tentative) | May 20, 2025 | |
| Credit of Share (Tentative) | May 20, 2025 | |
| Listing date (Tentative) | May 21, 2025 | |
| Anchor Lockin End date 1 | Jun 18, 2025 | |
| Anchor Lockin End date 2 | Aug 17, 2025 |
Accretion Pharmaceuticals IPO P/E ratio is 21.29, as compared to Indicosmic Infotech IPO P/E ratio of .
| Accretion Pharmaceuticals IPO | Indicosmic Infotech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Accretion Pharmaceuticals Limited Financial Information (Restated Consolidated)
| Indicosmic Capital Limited Financial Information (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 72.92 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.48 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 21.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹112.27 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 72.47% | 46.55% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.73% | 70.46% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.52 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.74 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 72.47% | 46.55% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Accretion Pharmaceuticals IPO Retail Individual Investors (RII) are offered 12,22,800 shares while in Indicosmic Infotech IPO retail investors are offered 12,22,800 shares. Qualified Institutional Buyers (QIB) are offered 1,41,600 shares in Accretion Pharmaceuticals IPO and in Indicosmic Infotech IPO.
| Accretion Pharmaceuticals IPO | Indicosmic Infotech IPO | |
|---|---|---|
| Anchor Investor Reserveration | 2,11,200 shares | |
| Market Maker Reserveration | 1,47,600 shares | |
| QIB | 1,41,600 shares | |
| NII | 12,22,800 shares | |
| RII | 12,22,800 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 27,98,400 shares |
Accretion Pharmaceuticals IPO subscribed 7.67x in total, whereas Indicosmic Infotech IPO subscribed .
| Accretion Pharmaceuticals IPO | Indicosmic Infotech IPO | |
|---|---|---|
| QIB (times) | 12.14x | |
| NII (times) | 4.28x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 10.54x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 7.67x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
